Form 8-K - Current report:
SEC Accession No. 0001297184-21-000029
Filing Date
2021-05-07
Accepted
2021-05-07 16:18:50
Documents
13
Period of Report
2021-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20210506x8k.htm   iXBRL 8-K 125400
2 EX-99.1 amph-20210506ex991723c92.htm EX-99.1 11190
  Complete submission text file 0001297184-21-000029.txt   266817

Data Files

Seq Description Document Type Size
3 EX-101.SCH amph-20210506.xsd EX-101.SCH 3210
4 EX-101.LAB amph-20210506_lab.xml EX-101.LAB 15497
5 EX-101.PRE amph-20210506_pre.xml EX-101.PRE 10521
6 EXTRACTED XBRL INSTANCE DOCUMENT amph-20210506x8k_htm.xml XML 4641
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 21902957
SIC: 2834 Pharmaceutical Preparations